• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Overlay Reps





i don’t work at BI...but for a company that uses overlay reps. This is how overlays are perceived by managers where I work. They are put on priority brands, see more priority targets, and are more highly skilled. It’s viewed as a specialty rep without having a devoted specialty division. But that’s where I work.